NCT01561963View on ClinicalTrials.gov

A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

February 1, 2012

Primary Completion Date

April 1, 2012

Study Completion Date

April 1, 2012

Conditions
Healthy Subjects
Interventions
DRUG

Apremilast

Tablets for oral administration

DRUG

Rifampin Oral Capsules

Capsules for oral administration

DRUG

Rifampin IV Solution

Intravenous (IV) solution

Trial Locations (1)

66211

Quintiles, Overland Park

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY